All blog posts
Total 34 results for
Showing 12 out of 34 results
22 January 2026
China’s Merger Review Guidelines: A Comparative Look against the EU Framework (Non-Horizontal)
14 August 2025
China’s First Unwinding Order: SAMR Blocks Completed Below-Threshold Pharma Deal
17 July 2025
China Releases the 2025 Anti-Unfair Competition Law
11 November 2024
Class actions radar: Scanning global trends and risks
13 September 2024
Shaping the future of Chinese competition policy: Insights into SAMR's draft rules for calculating fines for gun-jumping
10 November 2023
#FDIFriday: HSF Global FDI podcast - the Thai FDI regime
27 October 2023
#FDIFriday: HSF Global FDI podcast – the Chinese and Indonesian FDI regimes
25 April 2023
Highlights from the Amendments to Four Substantive Regulations in China
09 February 2023
Competition law developments in the pharma sector – 2022 round-up and what to expect in 2023
10 October 2022
A new milestone for Hong Kong's Competition Commission: First enforcement proceedings in relation to resale price maintenance
05 July 2022
HSF Asia-Pacific Competition Law Guide 2022 – now online
28 June 2022
More changes to come: China consults on amendments to six antitrust guidelines
Showing 12 out of 34 results
View moreKey contacts
Kyriakos Fountoukakos
Managing Partner, Competition/Antitrust, Regulation and Trade, Brussels
Veronica Roberts
Partner, Head of Competition/Antitrust, Regulation and Trade, UK, London
Linda Evans
Partner, Head of Competition/Antitrust, Regulation and Trade, Australia, Sydney
Adelaide Luke
Partner, Head of Competition, Asia, Hong Kong
Jean Meijer
Managing Partner, Johannesburg Office, Johannesburg and Africa Group
Kristien Geeurickx
Knowledge Counsel, London